December 5th 2024
Cambrex will provide Lilly’s biotech collaborators with accelerated access to clinical development capabilities.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Tackling Production Challenges through Greater Access to mRNA Technologies
November 27th 2023Chris Spivey, editorial director for Pharmaceutical Technology, discusses messenger RNA (mRNA) advances with Guillaume Roelandts, Head of Products and Marketing, Quantoom Biosciences, at the 11th International mRNA Health Conference in Berlin, Germany.
Centering Sustainability and Environmental Impact in the Supply Chain
November 23rd 2023Chris Spivey, editorial director for Pharmaceutical Technology and Biopharm International, spoke with Concetto Andrea Rizza, Marketing and Communications manager, ICE Pharma, on sustainability and ICE’s green approach at CPhI Barcelona 2023.
Democratizing GMP Manufacturing for the New Therapeutic Pipeline
November 21st 2023PharmTech Europe discusses technology that enables the “democratization” of mRNA manufacturing with Scott Ripley, general manager, Nucleic Acid Therapeutics and Precision Nanosystems, Cytiva, at the 11th International mRNA Health Conference in Berlin, Germany.